Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer

• DOI: 10.1007/s10147-014-0745-8
• Publication Date: 2014-09-05T05:25:49Z
• Authors: Arash O. Naghavi; Tobin J. Strom; Kevin Nethers; Alex A. Cruz; Nicholas B. Figura; Kushagra Shrinath; Binglin Yue; Jongphil Kim; Matthew C. Biagioli; Daniel C. Fernandez; Randy V. Heysek; Richard B. Wilder
• Keywords: Aged, 80 and over; Male; 03 medical and health sciences; 0302 clinical medicine; Humans; Prostatic Neoplasms; Middle Aged; Prostate-Specific Antigen; Aged; 3. Good health

The objectives are to determine predictors of a prostate-specific antigen (PSA) bounce, whether a PSA bounce after radiotherapy for prostate cancer is associated with biochemical disease-free survival (bDFS), and the time course to a PSA bounce versus a biochemical failure post-irradiation.Between July 2000 and December 2012, 691 prostate cancer patients without regional or distant metastases were treated with external beam radiation therapy and/or brachytherapy, and had at least 12 months of follow-up. A PSA bounce was defined as a temporary PSA increase of ≥ 0.4 ng/mL. bDFS was defined according to the nadir + 2 definition.The median follow-up was 42 months. The median time to first PSA bounce was 17 months (95% confidence interval 15-18 months). In contrast, the median time to biochemical failure was 41 months (95% confidence interval 28-53 months). Two hundred and twenty-six of 691 (33%) patients had at least one PSA bounce with a median magnitude of 1.0 ng/mL (range 0.4-17.0). A Gleason score of 6 (p < 0.0001) predicted a PSA bounce on multivariate analysis. Patients with a PSA bounce experienced improved bDFS on multivariate analysis (p = 0.002).Patients with a Gleason score of 6 were more likely to experience a PSA bounce which was associated with improved bDFS. A PSA bounce occurred sooner after radiotherapy than a biochemical failure. The authors recommend against performing prostate biopsies within 24-30 months of radiotherapy since an elevated PSA may simply represent a benign PSA bounce.